title: Chemoradiotherapy for maxillary sinus adenoid cystic carcinoma using superselective intra-arterial infusion via a superficial temporal artery.
abstract: BACKGROUND
  The efficacy of concurrent intra-arterial infusion chemoradiotherapy for adenoid cystic carcinoma (ACC) has been described in only a few reports. Herein, we report on 2 patients with unresectable ACC of the maxillary sinus treated with this approach.
  
  
  METHODS
  Patients received concurrent chemoradiotherapy. External beam radiation was administered 5 times a week at 2 Gray (Gy) per fraction for a total of 60 Gy. Chemotherapy consisting of docetaxel and cisplatin was administered by superselective intra-arterial infusion via a superficial temporal artery.
  
  
  RESULTS
  After the completion of all treatments in both patients, biopsy specimens of the primary lesions showed complete disappearance of all viable and nonviable tumor cells and new bone formation at the bony walls of the maxillary sinus. Although complications such as mucositis, neutropenia, and anorexia were observed, they were well-tolerated and manageable.
  
  
  CONCLUSIONS
  Concurrent chemoradiotherapy using superselective intra-arterial infusion is a potential option for patients with unresectable maxillary ACC.
authors.affiliation: Department of Oral and Maxillofacial Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan. madachi@mdanderson.org
authors.forename: Makoto
authors.initials: M
authors.lastname: Adachi
authors.forename: Kenji
authors.initials: K
authors.lastname: Mitsudo
authors.forename: Noriyuki
authors.initials: N
authors.lastname: Yamamoto
authors.forename: Sumitaka
authors.initials: S
authors.lastname: Hagiwara
authors.forename: Toshio
authors.initials: T
authors.lastname: Shigetomi
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Fujimoto
authors.forename: Stephen Y
authors.initials: SY
authors.lastname: Lai
authors.forename: Iwai
authors.initials: I
authors.lastname: Tohnai
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D003528:Carcinoma, Adenoid Cystic / Q000628:therapy*; D059248:Chemoradiotherapy / Q000379:methods*; D002945:Cisplatin / Q000008:administration & dosage* / Q000627:therapeutic use; D000077143:Docetaxel; D005260:Female; D006801:Humans; D007261:Infusions, Intra-Arterial / Q000379:methods*; D008297:Male; D008444:Maxillary Sinus Neoplasms / Q000473:pathology / Q000628:therapy*; D008875:Middle Aged; D043823:Taxoids / Q000008:administration & dosage* / Q000627:therapeutic use; D013699:Temporal Arteries; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D043823:Taxoids; D000077143:Docetaxel; D002945:Cisplatin